Teva Didn't Infringe OxyContin Patents, NY Judge Rules
By David McAfee ( January 14, 2014, 6:32 PM EST) -- A New York federal judge on Tuesday found that Teva Pharmaceuticals USA Inc. did not infringe any valid Purdue Pharma LP patent when it attempted to sell a generic version of narcotic pain medication OxyContin....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.